Clinical trial NCT05922956: Facial Emotion Recognition in Patients With Euthymic Bipolar Disorder I and II
Official title: Facial Emotion Recognition in Patients With Euthymic Bipolar Disorder I and II
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Social Cognition
Facial Emotion Recognition
Facial Affect
Bipolar Disorder I and II
Keywords: social cognition
facial emotion recognition
facial affect
bipolar disorder I and II
Lead sponsor: Centre Hospitalier Universitaire, Amiens
Sponsor class: OTHER
Collaborators: name: Centre Hospitalier le Vinatier
name: Pôle Ressource Évaluation et Réhabilitation Psycho-sociale, EPSM de l'Oise
name: Centre de santé mentale MGEN
name: Centre Hospitalier Philippe Pinel, Amiens
First posted: 2023-06-28
Enrollment: 10
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: NON_RANDOMIZED
Intervention model: PARALLEL
Primary purpose: OTHER

Brief summary: The facial emotion recognition is a basic social skill for successful social interactions. Several meta-analyses and recent studies found impairments of the perception of facial emotions in patients with euthymic bipolar disorder. Few studies compared recognition of facial emotions impairments during euthymia in patients with bipolar disorder type 1 and 2. These studies included low population samples (N\<60). There were discrepancies in results of these studies. Szanto suggested that facial emotion recognition impairments were correlated with suicidal risk and social isolation. These impairments should be taking into account regarding psycho-social treatments in patients with bipolar disorder.

This study aims to evaluate facial emotion recognition in patients with bipolar I and II disorders compared to healthy controls, using the facial emotion recognition test (TREF). The objective of the present study is to compare TREF scores in a group of patients with bipolar 1, a group of patients with bipolar 2 disorder and a group with healthy controls. In addition, the investigators will investigate the relationships between TREF scores and levels of self-esteem and mental well-being.


Eligibility criteria: Inclusion Criteria:

* Patient group :
* Male or female patients, between 18 and 60 years old
* Diagnosis of Bipolar Disorder I or Bipolar Disorder II according to DSM-IV criteria, using the French version of the Mini-International Neuropsychiatric Interview (MINI)
* Strictly euthymic defined by Hamilton Depression Rating Scale (17 items) ≤ 5 and Young Mania Rating Scale ≤ 5 for at least two months.
* Native French speakers
* Affiliated to the French social security system
* Giving their written informed consent

Control group :

* Male or female control subjects, aged between 18 and 60 years old, assessed using TREF
* Native French speakers
* Giving their written informed consent

Exclusion Criteria:

* Patient group :
* History of mental retardation assessed by the French version of the National Adult Reading Test
* Neurological illness or any clinical condition that could affect cognitive performance (history of head injury with loss of consciousness lasting more than 5 minutes multiple sclerosis, stroke etc.)
* Electroconvulsive therapy within the last 6 months
* Alcohol and Drug dependence (except tobacco and caffeine) according to DSM-IV criteria using the French version of the Mini-International Neuropsychiatric Interview (MINI).
* Learning disability or difficulty with fluent use of the French language
* Patient with mandatory care
* Long-Term use of non-psychotropic medication with psychotropic effects (opiates, Baclofen)

Control group :

* History of mental retardation estimated by the French version of the National Adult Reading Test
* Neurological illness or any clinical condition that could affect cognitive performance (history of head injury with loss of consciousness lasting more than 5 minutes multiple sclerosis, stroke etc.)
* Current Mood disorder/ Lifetime Psychotic Disorder according to DSM-IV criteria using the French version of the Mini-International Neuropsychiatric Interview (MINI)
* Neither history of psychotic or affective disorders in a first-degree family member
* Alcohol and Drug dependence (except tobacco and caffeine) according to DSM-IV criteria using the French version of the Mini-International Neuropsychiatric Interview (MINI)
* Learning disability or difficulty with fluent use of the French language
* Long-Term use of non-psychotropic drugs with psychotropic effects (opiates, Baclofen) and psychotropic drugs

Primary outcomes:
measure: variation of TREF scores in tree groups of subjects
timeFrame: 16 months
Secondary outcomes:
Other outcomes:
Locations:
city: Amiens
country: France
facility: CHU Amiens
Study officials:
References: